PCMRI - an MRI/TRUS System for the Evaluation of the Prostate
NCT00542100 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2007-10-10
Summary
The aim of the clinical study is to evaluate the convenience and efficacy of the PCMRI in the assessment of the prostate in humans.
The study cohort will include 50 patients and is designed to be non-comparative to other diagnostic methods.
Conditions
Interventions
- DEVICE
-
PCMRI
Sponsors & Collaborators
-
TopSpin Medical
lead INDUSTRY
Principal Investigators
-
Shmuel Cytron, MD. · Barzilai Medical Center, Ashkelon, Israel
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-11-30
- Completion
- 2008-11-30
More Related Trials
-
MRI Before Biopsy in Diagnosing Patients With Prostate Cancer
NCT02131207 ·Status: TERMINATED
-
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
NCT05141760 ·Status: COMPLETED ·Phase: PHASE2
-
MRI in Diagnosing Prostate Cancer
NCT01292291 ·Status: UNKNOWN ·Phase: NA
-
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
NCT07162194 ·Status: RECRUITING ·Phase: NA
-
Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy
NCT02488096 ·Status: COMPLETED ·Phase: NA
-
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04692675 ·Status: RECRUITING ·Phase: NA
-
Upright MRI for Prostate Cancer Screening
NCT03474913 ·Status: RECRUITING
-
EDRN Prostate MRI Biomarker Study
NCT03784924 ·Status: RECRUITING
-
MRI/MRSI in Risk Assessment of Prostate Cancer Patients
NCT00582543 ·Status: COMPLETED ·Phase: NA
-
Imaging of High Grade Prostate Cancer
NCT02177526 ·Status: TERMINATED ·Phase: NA
-
Predicting Prostate Biopsy Results With Biomarkers and mpMRI.
NCT03730324 ·Status: COMPLETED ·Phase: NA
-
ReIMAGINE Prostate Cancer Screening
NCT04063566 ·Status: COMPLETED ·Phase: NA
-
Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour
NCT05024162 ·Status: RECRUITING ·Phase: NA
-
MRI Screening in Men at High Risk of Developing Prostate Cancer
NCT05608694 ·Status: RECRUITING ·Phase: NA
-
Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development
NCT02106416 ·Status: COMPLETED ·Phase: NA
-
Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning
NCT02470910 ·Status: COMPLETED ·Phase: NA
-
Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA
NCT03187990 ·Status: COMPLETED ·Phase: NA
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer
NCT00924313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study
NCT04176497 ·Status: TERMINATED ·Phase: PHASE2
-
Prostate Cancer Screening Trial Using Imaging
NCT03702439 ·Status: COMPLETED
-
CT/MRI Co-registration Prostate Cancer
NCT00252460 ·Status: COMPLETED
-
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
NCT01834001 ·Status: RECRUITING
-
Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients
NCT03180398 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate Cancer
NCT01357512 ·Status: COMPLETED ·Phase: NA